Global prevalence of chronic kidney disease–a systematic review and meta-analysis

NR Hill, ST Fatoba, JL Oke, JA Hirst, CA O'Callaghan… - PloS one, 2016 - journals.plos.org
Chronic kidney disease (CKD) is a global health burden with a high economic cost to health
systems and is an independent risk factor for cardiovascular disease (CVD). All stages of …

Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review

K Brück, KJ Jager, E Dounousi, A Kainz… - Nephrology Dialysis …, 2015 - academic.oup.com
Background Many publications report the prevalence of chronic kidney disease (CKD) in the
general population. Comparisons across studies are hampered as CKD prevalence …

The co-existence of NASH and chronic kidney disease boosts cardiovascular risk: are there any common therapeutic options?

M Papademetriou, VG Athyros… - Current vascular …, 2018 - ingentaconnect.com
Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver
disease. NAFLD may evolve to non-alcoholic steatohepatitis (NASH), which is causally …

The inverse association of glomerular function and urinary β2-MG excretion and its implications for cadmium health risk assessment

S Satarug, DA Vesey, M Nishijo, W Ruangyuttikarn… - Environmental …, 2019 - Elsevier
Abstract Urinary β2-microgroblin (β2-MG) excretion levels above 300 μg/g creatinine are
used to indicate defective tubular reabsorption. Arguably, increased urinary β2-MG excretion …

Prevalence of secondary hyperparathyroidism in patients with stage 3 and 4 chronic kidney disease seen in internal medicine

JC Bureo, JC Arévalo, J Antón, G Adrados… - … y Nutrición (English …, 2015 - Elsevier
Objective Despite the high prevalence of chronic kidney disease in the elderly population,
few data are available on the frequency of secondary hyperparathyroidism in the Spanish …

Non-proteinuric diabetic nephropathy is the main cause of chronic kidney disease: results of a general population survey in Spain

NR Robles, J Villa, FJ Felix… - Diabetes & Metabolic …, 2017 - Elsevier
Background Diabetic nephropathy traditionally produces significant proteinuria prior to the
development of renal impairment. However, this clinical paradigm has recently been …

[HTML][HTML] Cardiovascular events and mortality in chronic kidney disease (stages I-IV)

B Quiroga, Ú Verdalles, J Reque… - Nefrologia (English …, 2013 - revistanefrologia.com
Introducción: Los eventos cardiovasculares (CV) son la primera causa de mortalidad en
pacientes con enfermedad renal crónica (ERC). El objetivo de nuestro estudio fue …

[HTML][HTML] The HUGE formula (hematocrit, urea, sex) for screening chronic kidney disease (CKD) in an age-stratified general population

NRR Perez-Monteoliva, FJ Felix, L Lozano… - The Journal of nutrition …, 2015 - Elsevier
Abstract Objectives: Aim To evaluate the screening power of the HUGE formula for the
detection of chronic kidney disease (CKD) in a Spanish population sample obtained from …

[PDF][PDF] Tratamiento eficaz de la arteriolopatía urémica calcificante con bifosfonatos

JV Torregrosa, CE Durán, X Barros, M Blasco… - Nefrología …, 2012 - SciELO Espana
TORREGROSA, José V. et al. Tratamiento eficaz de la arteriolopatía urémica calcificante
con bifosfonatos. Nefrología (Madr.)[online]. 2012, vol. 32, n. 3, pp. 329-334. ISSN 0211 …

[PDF][PDF] Eventos cardiovasculares y mortalidad en pacientes con enfermedad renal crónica (estadios I a IV)

B Quiroga, Ú Verdalles, J Reque… - Nefrología …, 2013 - SciELO Espana
QUIROGA, Borja et al. Eventos cardiovasculares y mortalidad en pacientes con enfermedad
renal crónica (estadios I a IV). Nefrología (Madr.)[online]. 2013, vol. 33, n. 4, pp. 539-545 …